Carvedilol ER 20 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB26FMBLE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,819
Award facts
- Contract value 100% obligated
- $2,818.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $2,818.98. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is October 31, 2025, with performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with an extensive portfolio of contract awards predominantly through the Defense Logistics Agency and its Medical Supply Chain. The company's federal contracts encompass a comprehensive range of pharmaceutical products across multiple therapeutic domains, including brand-name and generic medications, vaccines, and specialized medical supplies. All reviewed contract awards demonstrate consistent use of firm fixed-price delivery orders with competitive bidding, reflecting the company's established capability to meet federal procurement requirements. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen to continue serving defense and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FMBLE?
SPE2DB26FMBLE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FMBLE worth?
The government has obligated $2,819 on SPE2DB26FMBLE.
Is contract SPE2DB26FMBLE an order under another contract?
Yes. SPE2DB26FMBLE is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMBLE competed?
The extent of competition for SPE2DB26FMBLE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award